SYNICOM E/DROP (SYNIGAN)

SYNICOM E/DROP is a combination ophthalmic solution containing dorzolamide hydrochloride and timolol maleate. This dual-action medication is designed to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Dorzolamide works by decreasing aqueous humor production through carbonic anhydrase inhibition, while timolol, a beta-blocker, further reduces intraocular pressure through multiple mechanisms. Together, these active ingredients provide enhanced therapeutic efficacy for effective glaucoma management. Suitable for patients who require combination therapy for optimal pressure control. Available as an easy-to-administer eye drop formulation for convenient daily use.